Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-020803

Chief Financial Officer gave up 203 shares (to pay taxes)

  • Chief Financial Officer acquired 833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Foster Jonathan P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-16 Exercise or conversion : show line 1 in the form +833 12,196 D
2025-06-16 Shares withheld for taxes : show line 2 in the form −203 $0.69 $139 11,993 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −833 230,684 D
Loading xslF345X05/rdgdoc.xml…